Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:15 PM EDT

Bio-Techne (TECH) EBT Margin (QoQ) (2009 - 2026)

Analysis

Bio-Techne (TECH) EBT Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -87.00
Mar 31, 2026 571.00
Dec 31, 2025 42.00
Sep 30, 2025 2,396.00
Jun 30, 2025 -1,932.00
Mar 31, 2025 -233.00
Dec 31, 2024 56.00
Sep 30, 2024 27.00
Jun 30, 2024 -652.00
Mar 31, 2024 788.00
Dec 31, 2023 -565.00
Sep 30, 2023 -1,141.00
Jun 30, 2023 205.00
Mar 31, 2023 280.00
Dec 31, 2022 -1,400.00
Sep 30, 2022 1,104.00
Jun 30, 2022 374.00
Mar 31, 2022 -832.00
Dec 31, 2021 586.00
Sep 30, 2021 2,340.00